Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 for Methotrexate Hepatotoxicity in Pediatric ALL
NCT02373579Phase 2Completed
- Start
- Jun 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of omega-3 fatty acid in Methotrexate-induced hepatotoxicity. Started Jun 2012; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
Methotrexate-induced hepatotoxicity
Beyond the preview
Go deeper on NCT02373579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373579.